Detailed Information
Cited 9 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
MagnetisMM-7: An open-label, multicenter, randomized phase 3 study of elranatamab versus lenalidomide in post-transplant patients with newly diagnosed multiple myeloma.
- Authors
- Manteca, MVM[Manteca, Maria Victoria Mateos]; Grosicki, S[Grosicki, Sebastian]; Kim, K[Kim, Kihyun]; Negre, E[Negre, Eric]; Vandendries, E[Vandendries, Erik]
- Issue Date
- 1-Jun-2023
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.41, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 41
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.